SenesTech (NASDAQ: SNES), the rodent fertility control experts and inventors of the only EPA-registered contraceptive for male and female rats, presented virtually in a webcast presentation as part of of the Lytham Partners Fall 2023 Investor Conference. The company’s president and CEO Joel Fruendt and CFO Tom Chesterman joined Lytham Partners Managing Partner Robert Blum to provide an overview of the company and its unique positioning in the market. “At SenesTech, we have a significant opportunity to create something special. It’s why I joined the company in November of last year. We are addressing one of the world’s most challenging problems – rodent control – through a completely different way than has ever been done before by addressing the root cause of the problem – reproduction,” Fruendt said during the presentation. “The existing solutions’ effectiveness, namely poisons, that are in the marketplace are limited by rats’ reproduction rates, resistance and aversion as well well as the enhanced social and political limitations on the use of poison… As communities increasingly look to deploy sustainable, effective solutions, fertility control fits right in with that objective. Products that can be paradigm-changing don’t come along very often but, when they do, they have an opportunity to change the way things have been done for generations, and at SenesTech, we can do that.”
To view the full webcast, visit https://ibn.fm/Zdxrm
About SenesTech Inc.
SenesTech is an expert in animal fertility control. The company’s passion is to create a healthy environment by better controlling animal pest populations. Keeping an inescapable truth in mind—that two rats and their descendants can be responsible for the birth of up to 15,000 pups after a year—SenesTech invented ContraPest(R), the only U.S. EPA registered contraceptive for male and female rats, and Evolve(TM) minimum risk soft bait. Its products fit seamlessly into all integrated pest management programs, greatly improving the overall goal of effective pest management. SenesTech strives for clean cities, efficient businesses and happy households – with a product designed to be effective and sustainable. The company is committed to improving the health of the world by humanely managing animal populations through fertility control. For more information about the company, visit www.SenesTech.com.
NOTE TO INVESTORS: The latest news and updates relating to SNES are available in the company’s newsroom at https://ibn.fm/SNES
About InvestorWire
InvestorWire (“IW”) is a specialized communications platform with a focus on advanced wire-grade press release syndication for private and public companies and the investment community. It is one of 60+ brands within the Dynamic Brand Portfolio @ IBN that delivers: (1) access to a vast network of wire solutions via InvestorWire to efficiently and effectively reach a myriad of target markets, demographics and diverse industries; (2) article and editorial syndication to 5,000+ outlets; (3) enhanced press release enhancement to ensure maximum impact; (4) social media distribution via IBN to millions of social media followers; and (5) a full array of tailored corporate communications solutions. With broad reach and a seasoned team of contributing journalists and writers, IW is uniquely positioned to best serve private and public companies that want to reach a wide audience of investors, influencers, consumers, journalists and the general public. By cutting through the overload of information in today’s market, IW brings its clients unparalleled recognition and brand awareness. IW is where breaking news, insightful content and actionable information converge.
For more information, please visit https://www.InvestorWire.com
Please see full terms of use and disclaimers on the InvestorWire website applicable to all content provided by IW, wherever published or re-published: https://www.InvestorWire.com/Disclaimer
InvestorWire
Los Angeles, CA
www.InvestorWire.com
310.299.1717 Office
[email protected]
InvestorWire is powered by IBN